The global Gastrointestinal Cancer Treatment market size is expected to reach US$ 9225.2 million by 2029, growing at a CAGR of 12.6% from 2023 to 2029.

Gastrointestinal Cancer Treatment - Market

Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems. This report focus on Gastrointestinal Cancer Treatment market.

The market is mainly driven by the significant applications of Gastrointestinal Cancer Treatment in various end use industries. The expanding demands from the Hospitals, Clinics, Research Centers and Others, are propelling Gastrointestinal Cancer Treatment market. Surgery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Targeted Drugs Therapy segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gastrointestinal Cancer Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Gastrointestinal Cancer Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Gastrointestinal Cancer Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gastrointestinal Cancer Treatment sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Gastrointestinal Cancer Treatment covered in this report include Eli Lilly, F. Hoffmann, GlaxoSmithKline, Merck, Novartis AG, Otsuka Holdings, Stryker Corporation, Boston Scientific Corporation and Johnson and Johnson, etc.

The global Gastrointestinal Cancer Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Eli Lilly

F. Hoffmann

GlaxoSmithKline

Merck

Novartis AG

Otsuka Holdings

Stryker Corporation

Boston Scientific Corporation

Johnson and Johnson

CONMED Corporation

Bristol-Myers Squibb

Pfizer

Celltrion Inc

Amgen Limited

Celgene Corporation

Sanofi

Mylan N.V.

Samsung Bioepis

Teva Pharmaceutical Industries Ltd.

Scope of Gastrointestinal Cancer Treatment - Market Report

Report Metric	Details
Report Name	Gastrointestinal Cancer Treatment - Market
Forecasted market size in 2029	US$ 9225.2 million
CAGR	12.6%
Forecasted years	2023 - 2029
Global Gastrointestinal Cancer Treatment market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gastrointestinal Cancer Treatment market, Segment by Type:	Surgery Targeted Drugs Therapy Chemo Therapy Adjuvant Chemotherapy Radiation Therapy
Global Gastrointestinal Cancer Treatment market, by Application	Hospitals Clinics Research Centers Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gastrointestinal Cancer Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Gastrointestinal Cancer Treatment - Market size in 2029?

Ans: The Gastrointestinal Cancer Treatment - Market size in 2029 will be US$ 9225.2 million.

What are the Application segmentation covered in the Gastrointestinal Cancer Treatment - Market report?

Ans: The Applications covered in the Gastrointestinal Cancer Treatment - Market report are Hospitals, Clinics, Research Centers, Others

What are the Type segmentation covered in the Gastrointestinal Cancer Treatment - Market report?

Ans: The Types covered in the Gastrointestinal Cancer Treatment - Market report are Surgery, Targeted Drugs Therapy, Chemo Therapy, Adjuvant Chemotherapy, Radiation Therapy

1 Market Overview of Gastrointestinal Cancer Treatment

1.1 Gastrointestinal Cancer Treatment Market Overview

1.1.1 Gastrointestinal Cancer Treatment Product Scope

1.1.2 Gastrointestinal Cancer Treatment Market Status and Outlook

1.2 Global Gastrointestinal Cancer Treatment Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Gastrointestinal Cancer Treatment Market Size by Region (2018-2029)

1.4 Global Gastrointestinal Cancer Treatment Historic Market Size by Region (2018-2023)

1.5 Global Gastrointestinal Cancer Treatment Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Gastrointestinal Cancer Treatment Market Size (2018-2029)

1.6.1 North America Gastrointestinal Cancer Treatment Market Size (2018-2029)

1.6.2 Europe Gastrointestinal Cancer Treatment Market Size (2018-2029)

1.6.3 Asia-Pacific Gastrointestinal Cancer Treatment Market Size (2018-2029)

1.6.4 Latin America Gastrointestinal Cancer Treatment Market Size (2018-2029)

1.6.5 Middle East & Africa Gastrointestinal Cancer Treatment Market Size (2018-2029)

2 Gastrointestinal Cancer Treatment Market by Type

2.1 Introduction

2.1.1 Surgery

2.1.2 Targeted Drugs Therapy

2.1.3 Chemo Therapy

2.1.4 Adjuvant Chemotherapy

2.1.5 Radiation Therapy

2.2 Global Gastrointestinal Cancer Treatment Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Type (2018-2023)

2.2.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Gastrointestinal Cancer Treatment Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Gastrointestinal Cancer Treatment Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Gastrointestinal Cancer Treatment Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Gastrointestinal Cancer Treatment Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Gastrointestinal Cancer Treatment Revenue Breakdown by Type (2018-2029)

3 Gastrointestinal Cancer Treatment Market Overview by Application

3.1 Introduction

3.1.1 Hospitals

3.1.2 Clinics

3.1.3 Research Centers

3.1.4 Others

3.2 Global Gastrointestinal Cancer Treatment Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Application (2018-2023)

3.2.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Gastrointestinal Cancer Treatment Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Gastrointestinal Cancer Treatment Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Gastrointestinal Cancer Treatment Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Gastrointestinal Cancer Treatment Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Gastrointestinal Cancer Treatment Revenue Breakdown by Application (2018-2029)

4 Gastrointestinal Cancer Treatment Competition Analysis by Players

4.1 Global Gastrointestinal Cancer Treatment Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Treatment as of 2022)

4.3 Date of Key Players Enter into Gastrointestinal Cancer Treatment Market

4.4 Global Top Players Gastrointestinal Cancer Treatment Headquarters and Area Served

4.5 Key Players Gastrointestinal Cancer Treatment Product Solution and Service

4.6 Competitive Status

4.6.1 Gastrointestinal Cancer Treatment Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Eli Lilly

5.1.1 Eli Lilly Profile

5.1.2 Eli Lilly Main Business

5.1.3 Eli Lilly Gastrointestinal Cancer Treatment Products, Services and Solutions

5.1.4 Eli Lilly Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.1.5 Eli Lilly Recent Developments

5.2 F. Hoffmann

5.2.1 F. Hoffmann Profile

5.2.2 F. Hoffmann Main Business

5.2.3 F. Hoffmann Gastrointestinal Cancer Treatment Products, Services and Solutions

5.2.4 F. Hoffmann Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.2.5 F. Hoffmann Recent Developments

5.3 GlaxoSmithKline

5.3.1 GlaxoSmithKline Profile

5.3.2 GlaxoSmithKline Main Business

5.3.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Products, Services and Solutions

5.3.4 GlaxoSmithKline Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.3.5 Merck Recent Developments

5.4 Merck

5.4.1 Merck Profile

5.4.2 Merck Main Business

5.4.3 Merck Gastrointestinal Cancer Treatment Products, Services and Solutions

5.4.4 Merck Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.4.5 Merck Recent Developments

5.5 Novartis AG

5.5.1 Novartis AG Profile

5.5.2 Novartis AG Main Business

5.5.3 Novartis AG Gastrointestinal Cancer Treatment Products, Services and Solutions

5.5.4 Novartis AG Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.5.5 Novartis AG Recent Developments

5.6 Otsuka Holdings

5.6.1 Otsuka Holdings Profile

5.6.2 Otsuka Holdings Main Business

5.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Products, Services and Solutions

5.6.4 Otsuka Holdings Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.6.5 Otsuka Holdings Recent Developments

5.7 Stryker Corporation

5.7.1 Stryker Corporation Profile

5.7.2 Stryker Corporation Main Business

5.7.3 Stryker Corporation Gastrointestinal Cancer Treatment Products, Services and Solutions

5.7.4 Stryker Corporation Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.7.5 Stryker Corporation Recent Developments

5.8 Boston Scientific Corporation

5.8.1 Boston Scientific Corporation Profile

5.8.2 Boston Scientific Corporation Main Business

5.8.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Products, Services and Solutions

5.8.4 Boston Scientific Corporation Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.8.5 Boston Scientific Corporation Recent Developments

5.9 Johnson and Johnson

5.9.1 Johnson and Johnson Profile

5.9.2 Johnson and Johnson Main Business

5.9.3 Johnson and Johnson Gastrointestinal Cancer Treatment Products, Services and Solutions

5.9.4 Johnson and Johnson Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.9.5 Johnson and Johnson Recent Developments

5.10 CONMED Corporation

5.10.1 CONMED Corporation Profile

5.10.2 CONMED Corporation Main Business

5.10.3 CONMED Corporation Gastrointestinal Cancer Treatment Products, Services and Solutions

5.10.4 CONMED Corporation Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.10.5 CONMED Corporation Recent Developments

5.11 Bristol-Myers Squibb

5.11.1 Bristol-Myers Squibb Profile

5.11.2 Bristol-Myers Squibb Main Business

5.11.3 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Products, Services and Solutions

5.11.4 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.11.5 Bristol-Myers Squibb Recent Developments

5.12 Pfizer

5.12.1 Pfizer Profile

5.12.2 Pfizer Main Business

5.12.3 Pfizer Gastrointestinal Cancer Treatment Products, Services and Solutions

5.12.4 Pfizer Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.12.5 Pfizer Recent Developments

5.13 Celltrion Inc

5.13.1 Celltrion Inc Profile

5.13.2 Celltrion Inc Main Business

5.13.3 Celltrion Inc Gastrointestinal Cancer Treatment Products, Services and Solutions

5.13.4 Celltrion Inc Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.13.5 Celltrion Inc Recent Developments

5.14 Amgen Limited

5.14.1 Amgen Limited Profile

5.14.2 Amgen Limited Main Business

5.14.3 Amgen Limited Gastrointestinal Cancer Treatment Products, Services and Solutions

5.14.4 Amgen Limited Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.14.5 Amgen Limited Recent Developments

5.15 Celgene Corporation

5.15.1 Celgene Corporation Profile

5.15.2 Celgene Corporation Main Business

5.15.3 Celgene Corporation Gastrointestinal Cancer Treatment Products, Services and Solutions

5.15.4 Celgene Corporation Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.15.5 Celgene Corporation Recent Developments

5.16 Sanofi

5.16.1 Sanofi Profile

5.16.2 Sanofi Main Business

5.16.3 Sanofi Gastrointestinal Cancer Treatment Products, Services and Solutions

5.16.4 Sanofi Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.16.5 Sanofi Recent Developments

5.17 Mylan N.V.

5.17.1 Mylan N.V. Profile

5.17.2 Mylan N.V. Main Business

5.17.3 Mylan N.V. Gastrointestinal Cancer Treatment Products, Services and Solutions

5.17.4 Mylan N.V. Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.17.5 Mylan N.V. Recent Developments

5.18 Samsung Bioepis

5.18.1 Samsung Bioepis Profile

5.18.2 Samsung Bioepis Main Business

5.18.3 Samsung Bioepis Gastrointestinal Cancer Treatment Products, Services and Solutions

5.18.4 Samsung Bioepis Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.18.5 Samsung Bioepis Recent Developments

5.19 Teva Pharmaceutical Industries Ltd.

5.19.1 Teva Pharmaceutical Industries Ltd. Profile

5.19.2 Teva Pharmaceutical Industries Ltd. Main Business

5.19.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Products, Services and Solutions

5.19.4 Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Revenue (US$ Million) & (2018-2023)

5.19.5 Teva Pharmaceutical Industries Ltd. Recent Developments

6 North America

6.1 North America Gastrointestinal Cancer Treatment Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Gastrointestinal Cancer Treatment Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Gastrointestinal Cancer Treatment Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Gastrointestinal Cancer Treatment Market Dynamics

11.1 Gastrointestinal Cancer Treatment Industry Trends

11.2 Gastrointestinal Cancer Treatment Market Drivers

11.3 Gastrointestinal Cancer Treatment Market Challenges

11.4 Gastrointestinal Cancer Treatment Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Teva Pharmaceutical Industries Ltd

Boston Scientific Corporation

List of Tables

Table 1. Global Market Gastrointestinal Cancer Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Gastrointestinal Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Gastrointestinal Cancer Treatment Market Size Share by Region (2018-2023)

Table 4. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Gastrointestinal Cancer Treatment Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Gastrointestinal Cancer Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Gastrointestinal Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2018-2023)

Table 9. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2024-2029)

Table 11. North America Gastrointestinal Cancer Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Gastrointestinal Cancer Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Gastrointestinal Cancer Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Gastrointestinal Cancer Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Gastrointestinal Cancer Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Gastrointestinal Cancer Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Gastrointestinal Cancer Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Gastrointestinal Cancer Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Gastrointestinal Cancer Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Gastrointestinal Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Gastrointestinal Cancer Treatment Revenue Market Share by Application (2018-2023)

Table 24. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Gastrointestinal Cancer Treatment Revenue Market Share by Application (2024-2029)

Table 26. North America Gastrointestinal Cancer Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Gastrointestinal Cancer Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Gastrointestinal Cancer Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Gastrointestinal Cancer Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Gastrointestinal Cancer Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Gastrointestinal Cancer Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Gastrointestinal Cancer Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Gastrointestinal Cancer Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Gastrointestinal Cancer Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Gastrointestinal Cancer Treatment Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Gastrointestinal Cancer Treatment Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Treatment as of 2022)

Table 39. Date of Key Players Enter into Gastrointestinal Cancer Treatment Market

Table 40. Global Gastrointestinal Cancer Treatment Key Players Headquarters and Area Served

Table 41. Gastrointestinal Cancer Treatment Product Solution and Service

Table 42. Global Gastrointestinal Cancer Treatment Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Eli Lilly Basic Information List

Table 45. Eli Lilly Description and Business Overview

Table 46. Eli Lilly Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 47. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Eli Lilly (2018-2023)

Table 48. Eli Lilly Recent Developments

Table 49. F. Hoffmann Basic Information List

Table 50. F. Hoffmann Description and Business Overview

Table 51. F. Hoffmann Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 52. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of F. Hoffmann (2018-2023)

Table 53. F. Hoffmann Recent Developments

Table 54. GlaxoSmithKline Basic Information List

Table 55. GlaxoSmithKline Description and Business Overview

Table 56. GlaxoSmithKline Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 57. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of GlaxoSmithKline (2018-2023)

Table 58. GlaxoSmithKline Recent Developments

Table 59. Merck Basic Information List

Table 60. Merck Description and Business Overview

Table 61. Merck Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 62. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Merck (2018-2023)

Table 63. Merck Recent Developments

Table 64. Novartis AG Basic Information List

Table 65. Novartis AG Description and Business Overview

Table 66. Novartis AG Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 67. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Novartis AG (2018-2023)

Table 68. Novartis AG Recent Developments

Table 69. Otsuka Holdings Basic Information List

Table 70. Otsuka Holdings Description and Business Overview

Table 71. Otsuka Holdings Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 72. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Otsuka Holdings (2018-2023)

Table 73. Otsuka Holdings Recent Developments

Table 74. Stryker Corporation Basic Information List

Table 75. Stryker Corporation Description and Business Overview

Table 76. Stryker Corporation Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 77. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Stryker Corporation (2018-2023)

Table 78. Stryker Corporation Recent Developments

Table 79. Boston Scientific Corporation Basic Information List

Table 80. Boston Scientific Corporation Description and Business Overview

Table 81. Boston Scientific Corporation Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 82. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Boston Scientific Corporation (2018-2023)

Table 83. Boston Scientific Corporation Recent Developments

Table 84. Johnson and Johnson Basic Information List

Table 85. Johnson and Johnson Description and Business Overview

Table 86. Johnson and Johnson Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 87. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Johnson and Johnson (2018-2023)

Table 88. Johnson and Johnson Recent Developments

Table 89. CONMED Corporation Basic Information List

Table 90. CONMED Corporation Description and Business Overview

Table 91. CONMED Corporation Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 92. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of CONMED Corporation (2018-2023)

Table 93. CONMED Corporation Recent Developments

Table 94. Bristol-Myers Squibb Basic Information List

Table 95. Bristol-Myers Squibb Description and Business Overview

Table 96. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 97. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Bristol-Myers Squibb (2018-2023)

Table 98. Bristol-Myers Squibb Recent Developments

Table 99. Pfizer Basic Information List

Table 100. Pfizer Description and Business Overview

Table 101. Pfizer Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 102. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Pfizer (2018-2023)

Table 103. Pfizer Recent Developments

Table 104. Celltrion Inc Basic Information List

Table 105. Celltrion Inc Description and Business Overview

Table 106. Celltrion Inc Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 107. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Celltrion Inc (2018-2023)

Table 108. Celltrion Inc Recent Developments

Table 109. Amgen Limited Basic Information List

Table 110. Amgen Limited Description and Business Overview

Table 111. Amgen Limited Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 112. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Amgen Limited (2018-2023)

Table 113. Amgen Limited Recent Developments

Table 114. Celgene Corporation Basic Information List

Table 115. Celgene Corporation Description and Business Overview

Table 116. Celgene Corporation Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 117. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Celgene Corporation (2018-2023)

Table 118. Celgene Corporation Recent Developments

Table 119. Sanofi Basic Information List

Table 120. Sanofi Description and Business Overview

Table 121. Sanofi Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 122. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Sanofi (2018-2023)

Table 123. Sanofi Recent Developments

Table 124. Mylan N.V. Basic Information List

Table 125. Mylan N.V. Description and Business Overview

Table 126. Mylan N.V. Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 127. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Mylan N.V. (2018-2023)

Table 128. Mylan N.V. Recent Developments

Table 129. Samsung Bioepis Basic Information List

Table 130. Samsung Bioepis Description and Business Overview

Table 131. Samsung Bioepis Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 132. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Samsung Bioepis (2018-2023)

Table 133. Samsung Bioepis Recent Developments

Table 134. Teva Pharmaceutical Industries Ltd. Basic Information List

Table 135. Teva Pharmaceutical Industries Ltd. Description and Business Overview

Table 136. Teva Pharmaceutical Industries Ltd. Gastrointestinal Cancer Treatment Products, Services and Solutions

Table 137. Revenue (US$ Million) in Gastrointestinal Cancer Treatment Business of Teva Pharmaceutical Industries Ltd. (2018-2023)

Table 138. Teva Pharmaceutical Industries Ltd. Recent Developments

Table 139. North America Gastrointestinal Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 140. North America Gastrointestinal Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 141. Europe Gastrointestinal Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 142. Europe Gastrointestinal Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 143. Asia-Pacific Gastrointestinal Cancer Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 144. Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)

Table 145. Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2024-2029) & (US$ Million)

Table 146. Asia-Pacific Gastrointestinal Cancer Treatment Market Share by Region (2018-2023)

Table 147. Asia-Pacific Gastrointestinal Cancer Treatment Market Share by Region (2024-2029)

Table 148. Latin America Gastrointestinal Cancer Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 149. Latin America Gastrointestinal Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 150. Latin America Gastrointestinal Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 151. Middle East & Africa Gastrointestinal Cancer Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 152. Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 153. Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 154. Gastrointestinal Cancer Treatment Market Trends

Table 155. Gastrointestinal Cancer Treatment Market Drivers

Table 156. Gastrointestinal Cancer Treatment Market Challenges

Table 157. Gastrointestinal Cancer Treatment Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Gastrointestinal Cancer Treatment Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Gastrointestinal Cancer Treatment Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Gastrointestinal Cancer Treatment Market Share by Regions: 2022 VS 2029

Figure 4. Global Gastrointestinal Cancer Treatment Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Gastrointestinal Cancer Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Gastrointestinal Cancer Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Gastrointestinal Cancer Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Gastrointestinal Cancer Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Gastrointestinal Cancer Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Surgery

Figure 11. Global Surgery Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Targeted Drugs Therapy

Figure 13. Global Targeted Drugs Therapy Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Chemo Therapy

Figure 15. Global Chemo Therapy Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Product Picture of Adjuvant Chemotherapy

Figure 17. Global Adjuvant Chemotherapy Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 18. Product Picture of Radiation Therapy

Figure 19. Global Radiation Therapy Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 20. Global Gastrointestinal Cancer Treatment Market Size Share by Type: 2022 & 2029

Figure 21. North America Gastrointestinal Cancer Treatment Revenue Market Share by Type (2018-2029)

Figure 22. Europe Gastrointestinal Cancer Treatment Revenue Market Share by Type (2018-2029)

Figure 23. Asia-Pacific Gastrointestinal Cancer Treatment Revenue Market Share by Type (2018-2029)

Figure 24. Latin America Gastrointestinal Cancer Treatment Revenue Market Share by Type (2018-2029)

Figure 25. Middle East and Africa Gastrointestinal Cancer Treatment Revenue Market Share by Type (2018-2029)

Figure 26. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 27. Clinics Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 28. Research Centers Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 29. Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 30. Global Gastrointestinal Cancer Treatment Market Size Share by Application: 2022 & 2029

Figure 31. North America Gastrointestinal Cancer Treatment Revenue Market Share by Application (2018-2029)

Figure 32. Europe Gastrointestinal Cancer Treatment Revenue Market Share by Application (2018-2029)

Figure 33. Asia-Pacific Gastrointestinal Cancer Treatment Revenue Market Share by Application (2018-2029)

Figure 34. Latin America Gastrointestinal Cancer Treatment Revenue Market Share by Application (2018-2029)

Figure 35. Middle East and Africa Gastrointestinal Cancer Treatment Revenue Market Share by Application (2018-2029)

Figure 36. Gastrointestinal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 37. Global Top 5 and Top 10 Players Gastrointestinal Cancer Treatment Market Share in 2022

Figure 38. North America Gastrointestinal Cancer Treatment Market Share by Country (2018-2029)

Figure 39. U.S. Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 40. Canada Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 41. Germany Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 42. France Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 43. U.K. Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 44. Italy Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 45. Russia Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 46. Nordic Countries Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 47. Asia-Pacific Gastrointestinal Cancer Treatment Market Share by Region (2018-2029)

Figure 48. China Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 49. Japan Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 50. South Korea Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 51. Southeast Asia Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 52. India Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 53. Australia Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 54. Latin America Gastrointestinal Cancer Treatment Market Share by Country (2018-2029)

Figure 55. Mexico Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 56. Brazil Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 57. Middle East & Africa Gastrointestinal Cancer Treatment Market Share by Country (2018-2029)

Figure 58. Turkey Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 59. Saudi Arabia Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 60. UAE Gastrointestinal Cancer Treatment Market Size (2018-2029) & (US$ Million)

Figure 61. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions